{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:28:54Z","timestamp":1787671734282,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"crossref","award":["2020GXNSFAA297216"],"award-info":[{"award-number":["2020GXNSFAA297216"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Qinghai Science and Technology Department Project","award":["2020-ZJ-Y01"],"award-info":[{"award-number":["2020-ZJ-Y01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Infection with\n                      <jats:italic>Echinococcus multilocularis<\/jats:italic>\n                      causes alveolar echinococcosis (AE), a severe parasitic disease characterised by progressive hepatic infiltration and fibrosis. Current treatment options remain limited, and the immune-mediated mechanisms underlying fibrosis are not fully understood. This study investigated the role of the IL-33\/ST2 axis in AE-associated immunopathology and evaluated the effects of ST2 blockade in an experimental model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A murine model of AE was established in C57BL\/6 mice, which were allocated to untreated infected, anti-ST2\u2013treated infected and uninfected control groups. Liver pathology and fibrosis were assessed using haematoxylin and eosin staining, Masson\u2019s trichrome staining and transmission electron microscopy. Immune and fibrotic markers were analysed by immunohistochemistry and immunofluorescence. In parallel, liver samples from patients with AE were examined to evaluate translational relevance. Systemic cytokine profiles were quantified to assess immune modulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Analysis of human AE liver samples showed an increased expression of IL-33\/ST2 and associated immune and fibrotic markers, consistent with findings in the experimental mouse model. In infected mice, ST2 blockade significantly reduced metacestode lesion size and hepatic tissue invasion. This was accompanied by reduced fibrosis, as indicated by lower expression of \u03b1-smooth muscle actin, collagen I, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1. Anti-ST2 treatment was also associated with reduced hepatic infiltration of CD4\u207a T cells, B cells and M2 macrophages, along with decreased systemic levels of IFN-\u03b3, TNF-\u03b1, IL-4, IL-13, IL-17 and IL-1\u03b2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ST2 blockade reduced metacestode growth and was associated with attenuated hepatic inflammation and fibrosis, supporting a role for IL-33\/ST2 signalling in AE progression. Given the concurrent reduction in parasite burden, further studies are needed to determine whether the anti-fibrotic effects of ST2 inhibition are independent of parasite control.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-026-07462-6","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:44:50Z","timestamp":1781613890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ST2 blockade modulates IL-33\u2013driven immune responses and is associated with reduced hepatic fibrosis in alveolar echinococcosis"],"prefix":"10.1186","volume":"19","author":[{"given":"Emad","family":"Shamsan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Chuanchuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Haining","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"7462_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.5152\/eurasianjmed.2022.22308","volume":"54","author":"F Aydin","year":"2022","unstructured":"Aydin F, Yalcin A, Karaman A, Sade R, Ozturk G, Alper F. Diagnostic and management perspectives in alveolar echinococcosis: review of literature. Eurasian J Med. 2022;54:10\u20135.","journal-title":"Eurasian J Med"},{"key":"7462_CR2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i10.103973","volume":"31","author":"ET Pavlidis","year":"2025","unstructured":"Pavlidis ET, Galanis IN, Pavlidis TE. Current considerations for the management of liver echinococcosis. World J Gastroenterol. 2025;31:103973.","journal-title":"World J Gastroenterol"},{"key":"7462_CR3","doi-asserted-by":"publisher","first-page":"1497095","DOI":"10.3389\/fimmu.2025.1497095","volume":"16","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Wang J, Li H, Niu Q, Tao Y, Zhao X, et al. The role of the interleukin family in liver fibrosis. Front Immunol. 2025;16:1497095.","journal-title":"Front Immunol"},{"key":"7462_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02432","volume":"9","author":"OS Kotsiou","year":"2018","unstructured":"Kotsiou OS, Gourgoulianis KI, Zarogiannis SG. IL-33\/ST2 axis in organ fibrosis. Front Immunol. 2018;9:2432.","journal-title":"Front Immunol"},{"key":"7462_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.semcdb.2016.08.007","volume":"61","author":"NL Millar","year":"2017","unstructured":"Millar NL, O\u2019Donnell C, McInnes IB, Brint E. Wounds that heal and wounds that don\u2019t\u2014The role of the IL-33\/ST2 pathway in tissue repair and tumorigenesis. Semin Cell Dev Biol. 2017;61:41\u201350.","journal-title":"Semin Cell Dev Biol"},{"key":"7462_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04782-4","volume":"21","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Xu Z, Liu Z. Role of IL-33-ST2 pathway in regulating inflammation: current evidence and future perspectives. J Transl Med. 2023;21:902.","journal-title":"J Transl Med"},{"key":"7462_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cca.2019.05.023","volume":"495","author":"I Pusceddu","year":"2019","unstructured":"Pusceddu I, Dieplinger B, Mueller T. ST2 and the ST2\/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans. Clin Chim Acta. 2019;495:493\u2013500.","journal-title":"Clin Chim Acta"},{"key":"7462_CR8","doi-asserted-by":"publisher","first-page":"1533335","DOI":"10.3389\/fimmu.2025.1533335","volume":"16","author":"F Sheng","year":"2025","unstructured":"Sheng F, Li M, Yu JM, Yang SY, Zou L, Yang GJ, et al. IL-33\/ST2 axis in diverse diseases: regulatory mechanisms and therapeutic potential. Front Immunol. 2025;16:1533335.","journal-title":"Front Immunol"},{"key":"7462_CR9","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1038\/mi.2017.5","volume":"10","author":"A Pascual-Reguant","year":"2017","unstructured":"Pascual-Reguant A, Bayat Sarmadi J, Baumann C, Noster R, Cirera-Salinas D, Curato C, et al. T(H)17 cells express ST2 and are controlled by the alarmin IL-33 in the small intestine. Mucosal Immunol. 2017;10:1431\u201342.","journal-title":"Mucosal Immunol"},{"key":"7462_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210237","author":"L Maggi","year":"2023","unstructured":"Maggi L, Camelo GMA,\nRocha IC, Pereira Alves W,\nMoreira JMP, Almeida Pereira\nT, et al. Role of the IL-33\/ST2 activation pathway in the\ndevelopment of the hepatic\nfibrosis induced by\nSchistosoma mansoni granulomas in mice. Int J Mol\nSci. 2023;24:10237. https:\/\/doi.org\/10.3390\/ijms241210237.","journal-title":"Int J Mol Sci"},{"key":"7462_CR11","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04239-22","volume":"11","author":"B Autier","year":"2023","unstructured":"Autier B, Manuel C, Lundstroem-Stadelmann B, Girard JP, Gottstein B, Gangneux JP, et al. Endogenous IL-33 accelerates metacestode growth during late-stage alveolar echinococcosis. Microbiol Spectr. 2023;11:e0423922.","journal-title":"Microbiol Spectr"},{"key":"7462_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jdermsci.2022.07.009","volume":"107","author":"X Wu","year":"2022","unstructured":"Wu X, Ming B, Wu T, Gao R, Hu P, Tang J, et al. IL-33\/ST2 axis contributes to the dermal fibrosis of systemic sclerosis via promoting fibroblasts activation. J Dermatol Sci. 2022;107:95\u2013104.","journal-title":"J Dermatol Sci"},{"key":"7462_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5625\/lar.2017.33.2.119","volume":"33","author":"HK Song","year":"2017","unstructured":"Song HK, Hwang DY. Use of C57BL\/6N mice on the variety of immunological researches. Lab Anim Res. 2017;33:119\u201323.","journal-title":"Lab Anim Res"},{"key":"7462_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1236","volume":"12","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Li M, Li Z, Song J, Zhao W. Study on the mechanism of miRNAs on liver injury in the condition of Protoscocephalus alveolarus transhepatic portal vein infection. Immun Inflamm Dis. 2024;12:e1236.","journal-title":"Immun Inflamm Dis"},{"key":"7462_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4417-1","volume":"19","author":"A Abulizi","year":"2019","unstructured":"Abulizi A, Shao Y, Aji T, Li Z, Zhang C, Aini A, et al. Echinococcus multilocularis inoculation induces NK cell functional decrease through high expression of NKG2A in C57BL\/6 mice. BMC Infect Dis. 2019;19:792.","journal-title":"BMC Infect Dis"},{"key":"7462_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.5625\/lar.2017.33.2.124","volume":"33","author":"JY Choi","year":"2017","unstructured":"Choi JY, Kim HR, Kim KS, Jung YS, Cho JY, Hwang DY, et al. Comparative study of the immunological characteristics of three different C57BL\/6N mouse substrains. Lab Anim Res. 2017;33:124\u201331.","journal-title":"Lab Anim Res"},{"key":"7462_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jmii.2014.01.009","volume":"49","author":"CC Chuang","year":"2016","unstructured":"Chuang CC, Chen CW, Huang YT, Du WY. Anti-ST2 monoclonal antibody inhibits eosinophil infiltration in Angiostrongylus cantonensis-infected mice. J Microbiol Immunol Infect. 2016;49:91\u20136.","journal-title":"J Microbiol Immunol Infect"},{"key":"7462_CR18","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1101\/pdb.prot073411","volume":"2014","author":"RD Cardiff","year":"2014","unstructured":"Cardiff RD, Miller CH, Munn RJ. Manual hematoxylin and eosin staining of mouse tissue sections. Cold Spring Harb Protoc. 2014;2014:655\u20138.","journal-title":"Cold Spring Harb Protoc"},{"key":"7462_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/978-1-4939-8935-5_25","volume":"1897","author":"S Magaki","year":"2019","unstructured":"Magaki S, Hojat SA, Wei B, So A, Yong WH. An introduction to the performance of immunohistochemistry. Methods Mol Biol. 2019;1897:289\u201398.","journal-title":"Methods Mol Biol"},{"key":"7462_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2020.582218","volume":"14","author":"S Zaqout","year":"2020","unstructured":"Zaqout S, Becker LL, Kaindl AM. Immunofluorescence staining of paraffin sections step by step. Front Neuroanat. 2020;14:582218.","journal-title":"Front Neuroanat"},{"key":"7462_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.psj.2020.10.022","volume":"100","author":"XL Wu","year":"2021","unstructured":"Wu XL, Zou XY, Zhang M, Hu HQ, Wei XL, Jin ML, et al. Osteocalcin prevents insulin resistance, hepatic inflammation, and activates autophagy associated with high-fat diet-induced fatty liver hemorrhagic syndrome in aged laying hens. Poult Sci. 2021;100:73\u201383.","journal-title":"Poult Sci"},{"key":"7462_CR22","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","volume":"30","author":"NM Anderson","year":"2020","unstructured":"Anderson NM, Simon MC. The tumor microenvironment. Curr Biol. 2020;30:R921\u20135.","journal-title":"Curr Biol"},{"key":"7462_CR23","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s12055-024-01685-x","volume":"40","author":"Y Aydin","year":"2024","unstructured":"Aydin Y, Eren S, Ogul H. Pulmonary diffuse calcified multiple nodules in alveolar echinococcosis. Indian J Thorac Cardiovasc Surg. 2024;40:386\u20137.","journal-title":"Indian J Thorac Cardiovasc Surg"},{"key":"7462_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113330","volume":"143","author":"S Wu","year":"2024","unstructured":"Wu S, Jiao J, Wang N, He N, Wu Y, Jiang H, et al. Tregs ST2 deficiency enhances the abscopal anti-tumor response induced by microwave ablation. Int Immunopharmacol. 2024;143:113330.","journal-title":"Int Immunopharmacol"},{"key":"7462_CR25","doi-asserted-by":"publisher","first-page":"5948","DOI":"10.4049\/jimmunol.1500424","volume":"194","author":"T Nabekura","year":"2015","unstructured":"Nabekura T, Girard JP, Lanier LL. IL-33 receptor ST2 amplifies the expansion of NK cells and enhances host defense during mouse cytomegalovirus infection. J Immunol. 2015;194:5948\u201352.","journal-title":"J Immunol"},{"key":"7462_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/discim\/kyac006","volume":"1","author":"S Di Carmine","year":"2022","unstructured":"Di Carmine S, Scott MM, McLean MH, McSorley HJ. The role of interleukin-33 in organ fibrosis. Discov Immunol. 2022;1:kyac006.","journal-title":"Discov Immunol"},{"key":"7462_CR27","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41419-024-06746-y","volume":"15","author":"YE Yang","year":"2024","unstructured":"Yang YE, Hu MH, Zeng YC, Tseng YL, Chen YY, Su WC, et al. IL-33\/NF-\u03baB\/ST2L\/Rab37 positive-feedback loop promotes M2 macrophage to limit chemotherapeutic efficacy in lung cancer. Cell Death Dis. 2024;15:356.","journal-title":"Cell Death Dis"},{"key":"7462_CR28","doi-asserted-by":"publisher","first-page":"9745","DOI":"10.2147\/IJN.S268282","volume":"15","author":"Y Wu","year":"2020","unstructured":"Wu Y, Shi W, Wang H, Yue J, Mao Y, Zhou W, et al. Anti-ST2 nanoparticle alleviates lung inflammation by targeting ILC2s-CD4(+)T response. Int J Nanomed. 2020;15:9745\u201358.","journal-title":"Int J Nanomed"},{"key":"7462_CR29","doi-asserted-by":"publisher","first-page":"235.14","DOI":"10.4049\/jimmunol.204.Supp.235.14","volume":"204","author":"NJ Valeff","year":"2020","unstructured":"Valeff NJ, Ventimiglia MS, Quadrana F, Jensen F. ST2-expressing B1 B cells acquire an anti-inflammatory capacity during pregnancy in mice. J Immunol. 2020;204:235.14-.14.","journal-title":"J Immunol"},{"key":"7462_CR30","doi-asserted-by":"publisher","first-page":"12189","DOI":"10.7150\/thno.48028","volume":"10","author":"C Yin","year":"2020","unstructured":"Yin C, Liu B, Li Y, Li X, Wang J, Chen R, et al. IL-33\/ST2 induces neutrophil-dependent reactive oxygen species production and mediates gout pain. Theranostics. 2020;10:12189\u2013203.","journal-title":"Theranostics"},{"key":"7462_CR31","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s13071-020-04190-3","volume":"13","author":"A Lamberet","year":"2020","unstructured":"Lamberet A, Rostan O, Dion S, Jan A, Guegan H, Manuel C, et al. IL-33\/ST2 axis is involved in disease progression in the spleen during Leishmania donovani infection. Parasit Vectors. 2020;13:320.","journal-title":"Parasit Vectors"},{"key":"7462_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092676","author":"KM Larsen","year":"2018","unstructured":"Larsen KM, Minaya MK,\nVaish V, Pe\u00f1a MMO. The role\nof IL-33\/ST2 pathway in\ntumorigenesis. Int J Mol Sci. 2018;19:2676. https:\/\/doi.org\/10.3390\/ijms19092676.","journal-title":"Int J Mol Sci"},{"key":"7462_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.657803","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Zhang N, Shi J, Dai C, Wu S, Jiao M, et al. Allograft or recipient ST2 deficiency oppositely affected cardiac allograft vasculopathy via differentially altering immune cells infiltration. Front Immunol. 2021;12:657803.","journal-title":"Front Immunol"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-026-07462-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-026-07462-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-026-07462-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:53:20Z","timestamp":1787669600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13071-026-07462-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7462"],"URL":"https:\/\/doi.org\/10.1186\/s13071-026-07462-6","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures were approved by the Experimental Committee of Qinghai University (approval no. QHDX-2023-09) and were conducted in accordance with institutional guidelines. Human liver samples were obtained from patients diagnosed with AE at a cooperating hospital. The study protocol was approved by the relevant hospital and departmental ethics committees. All human samples and data were fully anonymised, and no personally identifiable information was collected or used.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement for consent for publication was waived by the ethics committee because the study used anonymised clinical samples and did not include any identifiable personal data.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"361"}}